InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Warnecke Steve B, Chairman & CEO. Director active across 2 companies, notably Evolutionary Genomics, INC.. In total, 3 disclosures have been recorded. Activity tracked since 19 May 2021. The latest transaction was filed on 19 May 2021 (Don). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Warnecke Steve B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
66,667 shares@ €0.5149100.0% of flowCommon StockSEC:0001079973-22-000665:0
37,500 shares0Common StockSEC:0001553350-21-000447:0
59,375 sharesCommon StockSEC:0001209191-16-087941:0
3 of 3 declarations
About Warnecke Steve B
Steve B. Warnecke is the Chairman & CEO of Evolutionary Genomics, Inc. In this role, he is responsible for the strategic and operational direction of the company. Evolutionary Genomics specializes in genomic technologies. Mr. Warnecke's experience in the biotechnology sector is essential for the company's growth and innovation.
